MTFB Tag

Motif Bio PLC – Fiscal Year 2018 Results

Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced financial results for the year ended December 31, 2018....

Read More

Motif Bio PLC – Half-year Report

Motif Bio plc (AIM: MTFB), a clinical-stage biopharmaceutical company specializing in developing novel antibiotics, today announced unaudited financial results for the half year ended June 30, 2018 and reported on...

Read More

Motif Bio Reports Fiscal Year 2017 Results

Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced financial results for the year ended December 31, 2017. Dr. Graham Lumsden, Chief Executive Officer,...

Read More